


Children with Alagille syndrome often have their growth misclassified using standard charts, leading to unnecessary anxiety and interventions. New condition-specific growth charts promise to provide a more accurate assessment, reducing the risk of over- or ...

Children with Alagille Syndrome often exhibit unique growth patterns that are poorly captured by standard growth charts. Implementing condition-specific growth charts can improve the identification of malnutrition and inform targeted nutritional interventio...

Young patients presenting with hepatocellular adenomas, especially in the absence of typical risk factors, warrant careful consideration for underlying germline mutations. Heightened vigilance and appropriate genetic testing can significantly impact surveil...

In MASLD, aspirin use alone correlated with lower all-cause mortality and fewer liver-related events over roughly three years in multi-institutional data, without establishing causality. Signals appear most decision-relevant when cardiovascular indications ...

In metabolic dysfunction-associated steatotic liver disease (MASLD), use of aspirin alone was associated with differences in risks of all-cause mortality and liver-related events over three years in a multi-institutional analysis. Findings are observational...

In metabolic dysfunction-associated steatotic liver disease (MASLD), aspirin exposure was associated with lower all-cause mortality and fewer liver-related events over a three-year horizon in a multi-institutional cohort. Signals align with antiplatelet and...

In metabolic dysfunction-associated steatotic liver disease, aspirin monotherapy was evaluated over three years for associations with all-cause mortality and liver-related events across multiple institutions. Adjusted time-to-event analyses examined effect ...